ENTRY       D00302                      Drug
NAME        Dipyridamole (JP18/USP/INN);
            Persantine (TN)
PRODUCT
  GENERIC   DIPYRIDAMOLE (ANI Pharmaceuticals)
            DIPYRIDAMOLE (Amneal Pharmaceuticals of New York LLC)
            DIPYRIDAMOLE (HF Acquisition Co LLC)
            DIPYRIDAMOLE (Henry Schein)
            DIPYRIDAMOLE (Hikma Pharmaceuticals USA)
            DIPYRIDAMOLE (Lannett Company)
            DIPYRIDAMOLE (Oxford Pharmaceuticals)
            DIPYRIDAMOLE (Proficient Rx LP)
            DIPYRIDAMOLE (Rising Pharmaceuticals)
            DIPYRIDAMOLE (Zydus Lifesciences Limited)
            DIPYRIDAMOLE (Zydus Pharmaceuticals USA)
FORMULA     C24H40N8O4
EXACT_MASS  504.3173
MOL_WEIGHT  504.6256
CLASS       Cardiovascular agent
             DG01509  Phosphodiesterase V inhibitor
            Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
REMARK      Therapeutic category: 2171
            ATC code: B01AC07
            Product: D00302<JP/US>
            Product (mixture): D11615<US>
EFFICACY    Vasodilator (coronary), Platelet aggregation inhibitor, Phosphodiesterase inhibitor
COMMENT     Pyrimido-pyrimidine derivative
TARGET      PDE5 [HSA:8654] [KO:K13762]
            PDE4A [HSA:5141] [KO:K13293]
  PATHWAY   hsa04022(8654)  cGMP-PKG signaling pathway
            hsa04024(5141)  cAMP signaling pathway
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC07 Dipyridamole
                  D00302  Dipyridamole (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Platelet Modifying Agents
               Platelet Modifying Agents, Other
                Dipyridamole
                 D00302  Dipyridamole (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               217  Vasodilators
                2171  Coronary dilators
                 D00302  Dipyridamole (JP18/USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01509  Phosphodiesterase V inhibitor
               D00302  Dipyridamole
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                D00302  Dipyridamole
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Phosphodiesterases
                PDE4A
                 D00302  Dipyridamole (JP18/USP/INN) &lt;JP/US&gt;
                PDE5
                 D00302  Dipyridamole (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00302  Dipyridamole
DBLINKS     CAS: 58-32-2
            PubChem: 7847368
            ChEBI: 4653
            PDB-CCD: H9F
            LigandBox: D00302
            NIKKAJI: J8.585E
ATOM        36
            1   C8y C    21.7700  -17.7144
            2   C8y C    21.7700  -16.3056
            3   C8y C    20.5532  -18.4130
            4   N5x N    22.9868  -18.4130
            5   C8y C    22.9868  -15.6127
            6   N5x N    20.5532  -15.6127
            7   N1y N    20.5532  -19.8103
            8   N5x N    19.3423  -17.7144
            9   C8y C    24.1919  -17.7144
            10  N1y N    22.9868  -14.2097
            11  N5x N    24.1919  -16.3056
            12  C8y C    19.3423  -16.3056
            13  C1x C    19.3423  -20.5089
            14  C1x C    21.7700  -20.5089
            15  N1c N    25.4087  -18.4073
            16  C1x C    24.2036  -13.5111
            17  C1x C    21.7757  -13.5052
            18  N1c N    18.1313  -15.6127
            19  C1x C    19.3423  -21.9121
            20  C1x C    21.7700  -21.9121
            21  C1b C    25.4087  -19.8103
            22  C1b C    26.6139  -17.7086
            23  C1x C    24.2036  -12.1079
            24  C1x C    21.7757  -12.1079
            25  C1b C    18.1313  -14.2097
            26  C1b C    16.9204  -16.3056
            27  C1x C    20.5532  -22.6048
            28  C1b C    26.6139  -20.5148
            29  C1b C    27.8306  -18.4073
            30  C1x C    22.9925  -11.4152
            31  C1b C    16.9204  -13.5052
            32  C1b C    15.7094  -15.6127
            33  O1a O    27.8306  -19.8103
            34  O1a O    29.0415  -17.7027
            35  O1a O    15.7094  -14.2097
            36  O1a O    14.4985  -16.3056
BOND        39
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 1
            6     3   7 1
            7     3   8 2
            8     4   9 2
            9     5  10 1
            10    5  11 2
            11    6  12 2
            12    7  13 1
            13    7  14 1
            14    9  15 1
            15   10  16 1
            16   10  17 1
            17   12  18 1
            18   13  19 1
            19   14  20 1
            20   15  21 1
            21   15  22 1
            22   16  23 1
            23   17  24 1
            24   18  25 1
            25   18  26 1
            26   19  27 1
            27   21  28 1
            28   22  29 1
            29   23  30 1
            30   25  31 1
            31   26  32 1
            32   28  33 1
            33   29  34 1
            34   31  35 1
            35   32  36 1
            36    8  12 1
            37    9  11 1
            38   20  27 1
            39   24  30 1
///
